Article

SCT promoter methylation is a highly discriminative biomarker for lung and many other cancers

2015-04-24

Abstract excerpt

Aberrant DNA methylation has long been implicated in cancers. In this work we present a highly discriminative DNA methylation biomarker for non-small cell lung cancers and fourteen other cancers. Based on 69 NSCLC cell lines and 257 cancer-free lung tissues we identified a CpG island in SCT gene promoter which was verified by qMSP experiment in 15 NSCLC cell lines and 3 immortalized human respiratory epithelium ce...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: fa426bf6-4449-53a5-aa34-cf2d7557fd4a
DOI: 10.1101/018515

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SCT promoter methylation is a highly discriminative biomarker for lung and many other cancersDOI 10.1101/018515Read

Identification of a panel of sensitive and specific DNA methylation markers for squamous cell lung cancerSemantic proximity Read

Circulating Tumor Cell Methylation Profiles Reveal the Classification and Evolution of Non-small Cell Lung CancerSemantic proximity Read

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypesSemantic proximity Read

A prognostic 11-DNA methylation signature for lung squamous cell carcinomaSemantic proximity Read

Genome-Wide Epigenomic Profiling of Primary Non-Small Cell Lung Cancer Reveals Specific and Recurrent DNA Methylation Alterations in Smoker Versus Never-Smoker PatientsSemantic proximity Read

Integrative epigenomic analyses of small cell lung cancer cells demonstrates the clinical translational relevance of gene body methylationSemantic proximity Read

Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.Semantic proximity Read

DNA methylation and nonsmall cell lung cancer.Semantic proximity Read

Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinomaSemantic proximity Read

Identification and validation of candidate epigenetic biomarkers in lung adenocarcinomaSemantic proximity Read

Development and validation of a 5mC-based prognostic model for lung adenocarcinoma survival.Semantic proximity Read

Cell-free Tumor Methylome Analysis of Small Cell Lung Cancer Patients Identifies Subgroups with Prognostic AssociationsSemantic proximity Read